France

France

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
0.81 2011 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
1.38 (1.30 - 1.44) 2019 Modelled IHME
1.4 (1.33 - 1.46) 2018 Modelled IHME
1.42 (1.35 - 1.48) 2017 Modelled IHME
1.43 (1.36 - 1.49) 2016 Modelled IHME
1.44 (1.36 - 1.50) 2015 Modelled IHME
1.45 (1.37 - 1.51) 2014 Modelled IHME
1.47 (1.40 - 1.53) 2013 Modelled IHME
1.49 (1.42 - 1.55) 2012 Modelled IHME
1.51 (1.44 - 1.57) 2011 Modelled IHME
1.52 (1.45 - 1.59) 2010 Modelled IHME
1.54 (1.46 - 1.60) 2009 Modelled IHME
1.55 (1.47 - 1.61) 2008 Modelled IHME
1.56 (1.48 - 1.63) 2007 Modelled IHME
1.57 (1.49 - 1.64) 2006 Modelled IHME
1.59 (1.50 - 1.66) 2005 Modelled IHME
1.6 (1.51 - 1.67) 2004 Modelled IHME
1.61 (1.52 - 1.68) 2003 Modelled IHME
1.62 (1.53 - 1.69) 2002 Modelled IHME
1.63 (1.54 - 1.70) 2001 Modelled IHME
1.65 (1.55 - 1.72) 2000 Modelled IHME
1.66 (1.57 - 1.73) 1999 Modelled IHME
1.66 (1.58 - 1.74) 1998 Modelled IHME
1.67 (1.59 - 1.74) 1997 Modelled IHME
1.68 (1.60 - 1.75) 1996 Modelled IHME
1.69 (1.60 - 1.76) 1995 Modelled IHME
1.7 (1.62 - 1.77) 1994 Modelled IHME
1.71 (1.63 - 1.78) 1993 Modelled IHME
1.72 (1.64 - 1.79) 1992 Modelled IHME
1.73 (1.65 - 1.81) 1991 Modelled IHME
1.75 (1.65 - 1.83) 1990 Modelled IHME
0.8 (0.70 - 0.90) 2010 Survey/reported Ramiere, 2016
0.7 (0.50 - 0.90) 2004 Survey/reported Meffre C , 2010
0.02 (0.02 - 0.03) 2015 Modelled WHO
0.5 (0.40 - 0.70) 2016 Modelled Razavi-Shearer et al, 2018
0.7 (0.50 - 0.90) 2004 Survey/reported ECDC
0.26 (0.25 - 0.27) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.05 - 0.09) 2019 Modelled IHME
0.07 (0.06 - 0.09) 2018 Modelled IHME
0.08 (0.06 - 0.10) 2017 Modelled IHME
0.09 (0.07 - 0.11) 2016 Modelled IHME
0.1 (0.08 - 0.12) 2015 Modelled IHME
0.12 (0.09 - 0.14) 2014 Modelled IHME
0.14 (0.11 - 0.17) 2013 Modelled IHME
0.16 (0.13 - 0.20) 2012 Modelled IHME
0.19 (0.15 - 0.24) 2011 Modelled IHME
0.22 (0.17 - 0.27) 2010 Modelled IHME
0.24 (0.19 - 0.30) 2009 Modelled IHME
0.28 (0.22 - 0.34) 2008 Modelled IHME
0.31 (0.24 - 0.38) 2007 Modelled IHME
0.33 (0.26 - 0.42) 2006 Modelled IHME
0.36 (0.27 - 0.45) 2005 Modelled IHME
0.37 (0.29 - 0.47) 2004 Modelled IHME
0.39 (0.30 - 0.49) 2003 Modelled IHME
0.4 (0.32 - 0.51) 2002 Modelled IHME
0.42 (0.32 - 0.53) 2001 Modelled IHME
0.43 (0.33 - 0.55) 2000 Modelled IHME
0.44 (0.34 - 0.56) 1999 Modelled IHME
0.45 (0.36 - 0.56) 1998 Modelled IHME
0.46 (0.37 - 0.57) 1997 Modelled IHME
0.48 (0.37 - 0.59) 1996 Modelled IHME
0.49 (0.38 - 0.60) 1995 Modelled IHME
0.51 (0.41 - 0.62) 1994 Modelled IHME
0.54 (0.43 - 0.65) 1993 Modelled IHME
0.56 (0.45 - 0.68) 1992 Modelled IHME
0.59 (0.47 - 0.72) 1991 Modelled IHME
0.62 (0.49 - 0.77) 1990 Modelled IHME
0.01 (0.01 - 0.01) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.4 (0.70 - 2.40) 2009 Survey/reported Sauvage C et al , 2015
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.60 - 0.70) 2011 Survey/reported Richaud-Eyraud E et al, 2015
Prisoners
Download
Value (%) Year Type Source
0.6 (0.10 - 2.10) 2013 Survey/reported Corinne B et al, 2015.
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,008,180 (953,804 - 1,054,760) 1990 Modelled IHME
1,005,010 (955,541 - 1,048,420) 1991 Modelled IHME
1,001,450 (952,465 - 1,043,600) 1992 Modelled IHME
997,577 (950,801 - 1,038,490) 1993 Modelled IHME
993,940 (944,378 - 1,035,550) 1994 Modelled IHME
990,994 (940,827 - 1,034,370) 1995 Modelled IHME
988,834 (939,412 - 1,030,830) 1996 Modelled IHME
987,463 (937,909 - 1,029,140) 1997 Modelled IHME
986,732 (936,426 - 1,029,780) 1998 Modelled IHME
986,476 (933,473 - 1,029,660) 1999 Modelled IHME
986,549 (932,139 - 1,030,780) 2000 Modelled IHME
986,313 (931,266 - 1,028,460) 2001 Modelled IHME
985,543 (930,994 - 1,027,620) 2002 Modelled IHME
984,417 (930,411 - 1,026,050) 2003 Modelled IHME
983,250 (931,005 - 1,026,500) 2004 Modelled IHME
982,266 (928,226 - 1,025,940) 2005 Modelled IHME
981,360 (928,420 - 1,022,520) 2006 Modelled IHME
980,095 (927,550 - 1,021,310) 2007 Modelled IHME
978,133 (930,716 - 1,018,720) 2008 Modelled IHME
975,321 (929,454 - 1,016,380) 2009 Modelled IHME
971,536 (926,181 - 1,012,230) 2010 Modelled IHME
965,821 (920,869 - 1,006,260) 2011 Modelled IHME
958,258 (912,495 - 998,452) 2012 Modelled IHME
950,341 (903,448 - 990,339) 2013 Modelled IHME
943,505 (893,475 - 983,008) 2014 Modelled IHME
938,897 (886,495 - 979,282) 2015 Modelled IHME
937,279 (891,194 - 975,209) 2016 Modelled IHME
934,894 (888,416 - 972,462) 2017 Modelled IHME
926,611 (880,953 - 961,335) 2018 Modelled IHME
912,929 (861,308 - 951,234) 2019 Modelled IHME
353,000 (291,000 - 443,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.64 (1.98 - 3.41) 2019 Modelled IHME
2.68 (2.03 - 3.47) 2018 Modelled IHME
2.74 (2.08 - 3.52) 2017 Modelled IHME
2.76 (2.10 - 3.55) 2016 Modelled IHME
2.86 (2.20 - 3.67) 2015 Modelled IHME
2.84 (2.19 - 3.64) 2014 Modelled IHME
2.91 (2.26 - 3.73) 2013 Modelled IHME
2.97 (2.30 - 3.80) 2012 Modelled IHME
3.01 (2.34 - 3.83) 2011 Modelled IHME
3.06 (2.37 - 3.90) 2010 Modelled IHME
3.09 (2.39 - 3.90) 2009 Modelled IHME
3.1 (2.40 - 3.92) 2008 Modelled IHME
3.12 (2.41 - 3.94) 2007 Modelled IHME
3.16 (2.44 - 4.01) 2006 Modelled IHME
3.22 (2.48 - 4.08) 2005 Modelled IHME
3.28 (2.53 - 4.16) 2004 Modelled IHME
3.46 (2.65 - 4.38) 2003 Modelled IHME
3.54 (2.71 - 4.49) 2002 Modelled IHME
3.6 (2.76 - 4.57) 2001 Modelled IHME
3.65 (2.80 - 4.63) 2000 Modelled IHME
3.72 (2.87 - 4.74) 1999 Modelled IHME
3.73 (2.88 - 4.76) 1998 Modelled IHME
3.68 (2.84 - 4.70) 1997 Modelled IHME
3.67 (2.83 - 4.62) 1996 Modelled IHME
3.62 (2.80 - 4.56) 1995 Modelled IHME
3.58 (2.75 - 4.54) 1994 Modelled IHME
3.54 (2.72 - 4.51) 1993 Modelled IHME
3.5 (2.68 - 4.50) 1992 Modelled IHME
3.5 (2.66 - 4.52) 1991 Modelled IHME
3.52 (2.66 - 4.54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,750 (1,314 - 2,259) 2019 Modelled IHME
1,770 (1,341 - 2,288) 2018 Modelled IHME
1,802 (1,371 - 2,316) 2017 Modelled IHME
1,808 (1,377 - 2,331) 2016 Modelled IHME
1,867 (1,435 - 2,401) 2015 Modelled IHME
1,850 (1,428 - 2,367) 2014 Modelled IHME
1,886 (1,460 - 2,413) 2013 Modelled IHME
1,916 (1,482 - 2,446) 2012 Modelled IHME
1,932 (1,499 - 2,458) 2011 Modelled IHME
1,952 (1,512 - 2,488) 2010 Modelled IHME
1,959 (1,516 - 2,476) 2009 Modelled IHME
1,959 (1,518 - 2,476) 2008 Modelled IHME
1,956 (1,513 - 2,474) 2007 Modelled IHME
1,969 (1,521 - 2,500) 2006 Modelled IHME
1,993 (1,534 - 2,527) 2005 Modelled IHME
2,016 (1,559 - 2,557) 2004 Modelled IHME
2,112 (1,622 - 2,679) 2003 Modelled IHME
2,150 (1,646 - 2,724) 2002 Modelled IHME
2,174 (1,667 - 2,756) 2001 Modelled IHME
2,186 (1,677 - 2,775) 2000 Modelled IHME
2,219 (1,711 - 2,827) 1999 Modelled IHME
2,215 (1,710 - 2,821) 1998 Modelled IHME
2,171 (1,677 - 2,778) 1997 Modelled IHME
2,158 (1,665 - 2,719) 1996 Modelled IHME
2,125 (1,643 - 2,677) 1995 Modelled IHME
2,093 (1,608 - 2,655) 1994 Modelled IHME
2,067 (1,589 - 2,632) 1993 Modelled IHME
2,035 (1,556 - 2,619) 1992 Modelled IHME
2,029 (1,544 - 2,624) 1991 Modelled IHME
2,031 (1,536 - 2,625) 1990 Modelled IHME
3,845 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 17) 2019 Modelled IHME
12 (8 - 17) 2018 Modelled IHME
12 (8 - 17) 2017 Modelled IHME
12 (8 - 17) 2016 Modelled IHME
12 (8 - 17) 2015 Modelled IHME
12 (8 - 17) 2014 Modelled IHME
12 (8 - 17) 2013 Modelled IHME
12 (8 - 17) 2012 Modelled IHME
12 (8 - 17) 2011 Modelled IHME
12 (8 - 17) 2010 Modelled IHME
12 (8 - 17) 2009 Modelled IHME
12 (9 - 17) 2008 Modelled IHME
12 (9 - 17) 2007 Modelled IHME
12 (9 - 18) 2006 Modelled IHME
12 (9 - 18) 2005 Modelled IHME
12 (9 - 18) 2004 Modelled IHME
12 (9 - 18) 2003 Modelled IHME
12 (9 - 18) 2002 Modelled IHME
13 (9 - 18) 2001 Modelled IHME
13 (9 - 18) 2000 Modelled IHME
13 (9 - 18) 1999 Modelled IHME
13 (9 - 18) 1998 Modelled IHME
13 (9 - 18) 1997 Modelled IHME
13 (9 - 18) 1996 Modelled IHME
13 (9 - 19) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
90 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
90 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
83 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
78 2012 Survey/reported WHO/UNICEF
74 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
51 2009 Survey/reported WHO/UNICEF
47 2008 Survey/reported WHO/UNICEF
42 2007 Survey/reported WHO/UNICEF
39 2006 Survey/reported WHO/UNICEF
35 2005 Survey/reported WHO/UNICEF
35 2004 Survey/reported WHO/UNICEF
28 2003 Survey/reported WHO/UNICEF
29 2002 Survey/reported WHO/UNICEF
28 2001 Survey/reported WHO/UNICEF
26 2000 Survey/reported WHO/UNICEF
24 1999 Survey/reported WHO/UNICEF
27 1998 Survey/reported WHO/UNICEF
91 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
109 2015 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.85 (0.70 - 1.04) 2019 Modelled IHME
0.85 (0.69 - 1.03) 2018 Modelled IHME
0.84 (0.69 - 1.03) 2017 Modelled IHME
0.84 (0.69 - 1.02) 2016 Modelled IHME
0.84 (0.68 - 1.03) 2015 Modelled IHME
0.84 (0.68 - 1.03) 2014 Modelled IHME
0.84 (0.68 - 1.03) 2013 Modelled IHME
0.84 (0.69 - 1.03) 2012 Modelled IHME
0.84 (0.69 - 1.03) 2011 Modelled IHME
0.84 (0.69 - 1.04) 2010 Modelled IHME
0.83 (0.68 - 1.01) 2009 Modelled IHME
0.8 (0.65 - 0.96) 2008 Modelled IHME
0.75 (0.62 - 0.90) 2007 Modelled IHME
0.71 (0.59 - 0.85) 2006 Modelled IHME
0.69 (0.57 - 0.83) 2005 Modelled IHME
0.68 (0.57 - 0.82) 2004 Modelled IHME
0.67 (0.56 - 0.81) 2003 Modelled IHME
0.67 (0.56 - 0.80) 2002 Modelled IHME
0.66 (0.55 - 0.80) 2001 Modelled IHME
0.66 (0.55 - 0.80) 2000 Modelled IHME
0.67 (0.56 - 0.81) 1999 Modelled IHME
0.68 (0.57 - 0.83) 1998 Modelled IHME
0.7 (0.58 - 0.86) 1997 Modelled IHME
0.72 (0.59 - 0.88) 1996 Modelled IHME
0.74 (0.60 - 0.89) 1995 Modelled IHME
0.74 (0.61 - 0.90) 1994 Modelled IHME
0.75 (0.62 - 0.90) 1993 Modelled IHME
0.75 (0.62 - 0.91) 1992 Modelled IHME
0.75 (0.62 - 0.91) 1991 Modelled IHME
0.76 (0.62 - 0.92) 1990 Modelled IHME
0.3 (0.10 - 0.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.17 (0.08 - 0.20) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
63.8 2011 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
1 (0.90 - 1.20) 2010 Survey/reported Ramiere, 2016
0.84 (0.65 - 1.10) 2004 Survey/reported Meffre C et al, 2010
0.6 (0.40 - 1.10) 2014 Modelled Gower et al, 2014
0.84 2019 Modelled Jin et al. 2017
0.84 (0.80 - 1.10) 2004 Survey/reported ECDC
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 (0.50 - 1.90) 2009 Survey/reported Sauvage C et al , 2015
4.2 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
5.6 (4 - 7.50) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
62.2 (59.40 - 64.90) 2011 Survey/reported Weill-Barillet L et al, 2016
Prisoners
Download
Value (%) Year Type Source
6.3 (6.10 - 6.50) 2016 Modelled ECDC
4.8 2013 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
436,706 (355,338 - 529,133) 1990 Modelled IHME
437,680 (358,620 - 527,590) 1991 Modelled IHME
437,285 (359,830 - 526,520) 1992 Modelled IHME
435,774 (359,708 - 526,691) 1993 Modelled IHME
433,617 (355,122 - 524,795) 1994 Modelled IHME
431,246 (350,366 - 524,710) 1995 Modelled IHME
425,717 (349,594 - 516,940) 1996 Modelled IHME
416,128 (344,568 - 505,262) 1997 Modelled IHME
405,796 (337,661 - 489,953) 1998 Modelled IHME
398,076 (331,263 - 482,823) 1999 Modelled IHME
396,399 (329,407 - 479,670) 2000 Modelled IHME
399,846 (331,067 - 482,323) 2001 Modelled IHME
405,056 (338,121 - 487,591) 2002 Modelled IHME
411,739 (343,204 - 493,596) 2003 Modelled IHME
419,655 (348,808 - 502,364) 2004 Modelled IHME
428,517 (354,683 - 514,931) 2005 Modelled IHME
445,363 (370,318 - 531,410) 2006 Modelled IHME
472,486 (392,080 - 565,774) 2007 Modelled IHME
502,277 (413,320 - 606,158) 2008 Modelled IHME
527,022 (431,105 - 642,155) 2009 Modelled IHME
538,874 (441,258 - 663,432) 2010 Modelled IHME
540,990 (443,797 - 663,522) 2011 Modelled IHME
542,194 (442,617 - 664,235) 2012 Modelled IHME
543,075 (442,817 - 667,587) 2013 Modelled IHME
544,184 (444,590 - 668,016) 2014 Modelled IHME
545,898 (443,864 - 672,139) 2015 Modelled IHME
549,138 (449,329 - 672,277) 2016 Modelled IHME
553,199 (451,427 - 678,250) 2017 Modelled IHME
558,240 (457,645 - 678,288) 2018 Modelled IHME
564,899 (464,402 - 691,765) 2019 Modelled IHME
194,000 (93,000 - 222,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
24,200 (11,500 - 27,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.09 (6.60 - 9.63) 2019 Modelled IHME
8.11 (6.62 - 9.64) 2018 Modelled IHME
8.15 (6.63 - 9.73) 2017 Modelled IHME
8.06 (6.56 - 9.60) 2016 Modelled IHME
8.17 (6.60 - 9.74) 2015 Modelled IHME
8.04 (6.51 - 9.53) 2014 Modelled IHME
8.12 (6.66 - 9.64) 2013 Modelled IHME
8.16 (6.68 - 9.77) 2012 Modelled IHME
8.14 (6.65 - 9.77) 2011 Modelled IHME
8.11 (6.62 - 9.74) 2010 Modelled IHME
8.03 (6.57 - 9.68) 2009 Modelled IHME
7.93 (6.47 - 9.58) 2008 Modelled IHME
7.79 (6.40 - 9.41) 2007 Modelled IHME
7.72 (6.33 - 9.35) 2006 Modelled IHME
7.71 (6.29 - 9.34) 2005 Modelled IHME
7.68 (6.28 - 9.31) 2004 Modelled IHME
7.86 (6.50 - 9.54) 2003 Modelled IHME
7.85 (6.44 - 9.54) 2002 Modelled IHME
7.82 (6.40 - 9.52) 2001 Modelled IHME
7.83 (6.40 - 9.50) 2000 Modelled IHME
7.97 (6.52 - 9.69) 1999 Modelled IHME
7.92 (6.45 - 9.69) 1998 Modelled IHME
7.75 (6.28 - 9.49) 1997 Modelled IHME
7.66 (6.18 - 9.36) 1996 Modelled IHME
7.48 (6.02 - 9.11) 1995 Modelled IHME
7.31 (5.88 - 8.87) 1994 Modelled IHME
7.11 (5.73 - 8.65) 1993 Modelled IHME
6.92 (5.58 - 8.46) 1992 Modelled IHME
6.82 (5.50 - 8.38) 1991 Modelled IHME
6.75 (5.42 - 8.34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
5,356 (4,369 - 6,375) 2019 Modelled IHME
5,353 (4,373 - 6,365) 2018 Modelled IHME
5,367 (4,363 - 6,406) 2017 Modelled IHME
5,287 (4,304 - 6,294) 2016 Modelled IHME
5,340 (4,315 - 6,367) 2015 Modelled IHME
5,228 (4,237 - 6,199) 2014 Modelled IHME
5,260 (4,314 - 6,244) 2013 Modelled IHME
5,261 (4,306 - 6,293) 2012 Modelled IHME
5,221 (4,261 - 6,265) 2011 Modelled IHME
5,175 (4,225 - 6,216) 2010 Modelled IHME
5,096 (4,168 - 6,144) 2009 Modelled IHME
5,008 (4,087 - 6,051) 2008 Modelled IHME
4,890 (4,019 - 5,906) 2007 Modelled IHME
4,814 (3,950 - 5,833) 2006 Modelled IHME
4,777 (3,895 - 5,783) 2005 Modelled IHME
4,726 (3,865 - 5,731) 2004 Modelled IHME
4,804 (3,972 - 5,830) 2003 Modelled IHME
4,764 (3,910 - 5,790) 2002 Modelled IHME
4,715 (3,861 - 5,741) 2001 Modelled IHME
4,692 (3,835 - 5,696) 2000 Modelled IHME
4,748 (3,883 - 5,773) 1999 Modelled IHME
4,695 (3,828 - 5,749) 1998 Modelled IHME
4,580 (3,711 - 5,604) 1997 Modelled IHME
4,506 (3,636 - 5,506) 1996 Modelled IHME
4,385 (3,528 - 5,343) 1995 Modelled IHME
4,275 (3,440 - 5,189) 1994 Modelled IHME
4,147 (3,340 - 5,045) 1993 Modelled IHME
4,026 (3,246 - 4,923) 1992 Modelled IHME
3,954 (3,188 - 4,857) 1991 Modelled IHME
3,901 (3,132 - 4,820) 1990 Modelled IHME
4,917 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
45 (35 - 55) 2019 Modelled IHME
46 (36 - 55) 2018 Modelled IHME
46 (36 - 56) 2017 Modelled IHME
46 (36 - 55) 2016 Modelled IHME
46 (36 - 56) 2015 Modelled IHME
46 (36 - 55) 2014 Modelled IHME
45 (36 - 55) 2013 Modelled IHME
45 (36 - 55) 2012 Modelled IHME
45 (36 - 55) 2011 Modelled IHME
45 (35 - 55) 2010 Modelled IHME
45 (35 - 55) 2009 Modelled IHME
45 (35 - 55) 2008 Modelled IHME
44 (34 - 54) 2007 Modelled IHME
44 (34 - 54) 2006 Modelled IHME
44 (33 - 54) 2005 Modelled IHME
43 (33 - 54) 2004 Modelled IHME
43 (33 - 53) 2003 Modelled IHME
43 (32 - 53) 2002 Modelled IHME
42 (32 - 53) 2001 Modelled IHME
42 (32 - 53) 2000 Modelled IHME
42 (32 - 52) 1999 Modelled IHME
42 (32 - 52) 1998 Modelled IHME
42 (32 - 52) 1997 Modelled IHME
42 (31 - 52) 1996 Modelled IHME
42 (31 - 52) 1995 Modelled IHME
41 (31 - 52) 1994 Modelled IHME
41 (31 - 52) 1993 Modelled IHME
41 (31 - 51) 1992 Modelled IHME
40 (31 - 51) 1991 Modelled IHME
40 (30 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
109 2015 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019

Number of persons treated for HCV

National
Download
Value Year Type Source
17,325 2017 Survey/reported ECDC, 2019
17,325 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.38 (%)
2019
(1.3 - 1.44(%))
IHME
HCV (RNA/cAg+)
0.85 (%)
2019
(0.7 - 1.04(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.8 (%)
2010
(0.7 - 0.9(%))
Ramiere, 2016
HCV (anti-HCV)
1 (%)
2010
(0.9 - 1.2(%))
Ramiere, 2016

Hepatitis related deaths (national)

Modelled

HBV
1,750
2019
(1,314 - 2,259)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5,356
2019
(4,369 - 6,375)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.07 (%)
2019, latest modelled
(0.05 - 0.09(%))
IHME

Prevalence PWID

HCV
62.20 (%)
2011, survey/surveillance
(59.40 - 64.90(%))
Weill-Barillet L et al, 2016

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
109
2015
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources